CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for EastPharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

EastPharma Ltd
Clarendon House, 2 Church Street
Phone: +90 2126929292p:+90 2126929292 HAMILTON, HM 11  Bermuda Ticker: EASTEAST

Business Summary
EastPharma Ltd. is the indirect holding company of Deva Holding A.S. (Deva), a pharmaceutical company. The Company operates in the pharmaceutical industry. The Company has three segments: production and sale of human pharmaceuticals (Human Pharma), Veterinary Products and Other. The Human Pharma segment comprises the manufacturing and sale of antibiotic active ingredients and empty ampoules. The Veterinary products segment operates in the sector of veterinary drugs and agrochemicals. Its Other segment includes cologne production and sale. The Company offers medicines indicated for alimentary, metabolism and cardiovascular system and infections. It also conducts, at its microbiology laboratories, tests and research on the adaptation of raw materials, selection of micro-organisms, formulation of culture mediums, and executes various test and research fermentations on pilot fermentators. It has over 150 pharmaceutical molecules in approximately 270 pharmaceutical forms.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201812/31/2018Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Philipp D.Haas
Member of the Board, Chief Legal Advisor AyselOlcen Aydiner 37
Member of the Board Peter W.Baird
4 additional Officers and Directors records available in full report.

Business Names
Business Name
63PE
EAST
Hangzhou East Pharmaceutical Co., Ltd.

General Information
Number of Employees: 1,765 (As of 12/31/2007)
Outstanding Shares: 67,650,000 (As of 12/31/2018)
Stock Exchange: LON
Fax Number: +90 2126970024


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, December 21, 2023